TY  - JOUR 
AU  - Constenla Figueiras, Manuel
PY  - 2013
SN  - 1699-048X
UR  - http://hdl.handle.net/20.500.11940/2126
LA  - eng
TI  - Panitumumab and irinotecan every 3 weeks is an active and convenient regimen for second-line treatment of patients with wild-type K-RAS metastatic colorectal cancer
DO  - 10.1007/s12094-012-0993-x
T2  - Clinical & Translational Oncology
M2  - 705
VL  - 15
ER  -